Advertisement
Screener

Immuneering Corporation (IMRX) ROE

Immuneering Corporation (IMRX) ROE

  • 2026-06-30: ROE -30.03%.
  • 2026-03-31: ROE -26.36%.
  • 2025-12-31: ROE -25.64%.
  • 2025-09-30: ROE -27.41%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-30.03%
2026-03-31-26.36%
2025-12-31-25.64%
2025-09-30-27.41%
2025-06-30-214.71%
2025-03-31-147.64%
2024-12-31-147.48%
2024-09-30-100.60%
2024-06-30-84.56%
2024-03-31-68.82%
2023-12-31-59.03%
2023-09-30-49.64%
2023-06-30-45.07%
2023-03-31-52.38%
2022-12-31-45.98%
2022-09-30-39.42%
2022-06-30-32.74%
2022-03-31-27.91%
2021-12-31-21.50%
2021-09-30-18.06%
2021-06-3069.49%
2021-03-3170.35%
2020-12-3175.80%

Annual ROE

DateROE
2025-12-31-25.64%
2024-12-31-147.48%
2023-12-31-59.03%
2022-12-31-45.98%
2021-12-31-21.50%
2020-12-3175.80%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quantum Cyber N.V. (QUCY)$0.113B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80